Cranston, Rhode Island, August 5, 2014—Thomas H. Huling is a world leader in international finance and investments. For over 27 years, he has brought his expertise to the field of multinational business. Thomas H. Huling has founded and directed several businesses over the last couple of decades; however, one of his most recent business projects, Global MedInvent, LLC, is turning many heads these days.

Global MedInvent is a U.S. based company that focuses on medical inventions and innovative pharmaceutical solutions. Thomas H. Huling says the company has three core opportunities designed to accelerate innovations. Huling outlined the team at Global MedInvent, which consists of leading strategists and management experts as well as some of the leading clinicians and researchers.

A representative from the group said that she was “excited to be a part of such innovative and groundbreaking research, especially in a moment where we could really benefit from some of these technologies.” The group at Global MedInvent, along with Thomas H. Huling, are working to find innovative solutions to some of the world’s leading causes of death through medical technology and pharmaceutical industries.

Most of the technology being developed at Global MedInvent is focused on making medical procedures less invasive. Using micro diagnostic devices and drug delivery mechanisms changes the way we treat illnesses like cancer and cardiovascular diseases. Also, the company has access to the world’s smallest surgical camera, which allows for tumors and other obstructions to be located and removed in earlier stages, increasing the chances of survival.

Founder Thomas H. Huling notes, “What we are doing at Global MedInvent is pretty phenomenal. By using the smallest technologies available, we can treat serious diseases with very few invasive components, so people heal faster.” This is one of the reasons that Thomas H. Huling, an expert in investments and financing, suggests funding this research now. Thomas H. Huling sees that medical technologies are exploding right now, and with this momentum, it is a great time to invest.

Thomas H. Huling founded Global MedInvent in January of 2014, which means that now is the time to fund innovative medical technology research. Thomas H. Huling says that the company is positioned strategically to either build on their current research or bring the company’s medical technologies to market.

For More Information Visit at https://www.crunchbase.com/person/thomas-h-huling